Experimental Information |
|
Enzymatic Activity |
Molecule Id | EGIN0001016 |
PMID | 17184594 |
Assay Used | Tyrosine Kinase assays by ELISA, Cell growth inhibition assay by sulforhodamine B(SRB),Cell growth inhibition assay by MTT |
Experimently Validated | Yes |
EGFR (IC50) | - |
HER2 (IC50) | - |
HER4 (IC50) | - |
Mutant L858R (IC50) | - |
Mutant T790M (IC50) | - |
Double Mutant (IC50) | - |
Average ERBB2 and ERBB1 (IC50) | - |
Inhibition EGFR (%) | 35.50% |
Inhibitory Concentration | 10 µM/L |
Inhibition HER2 (%) | - |
Inhibitory Concentration | - |
Ki (EGFR) | - |
Ki (HER2) | - |
Ki (HER4) | - |
Kd (EGFR) | - |
Kd (L858R) | - |
Kd (T790M) | - |
Kd (L858R/T790M) | - |
Kd (Other mutation) | - |
Note | The paper describes the 3,5-substituted indolin-2-one derivatives as antitumor agents |
Extra | - |
| |